Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03572400
Brief Title: Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

First Submitted : June 18, 2018
First Submitted that Met QC Criteria : June 26, 2018
First Posted : June 28, 2018

Last Update Submitted that Met QC Criteria : September 26, 2019
Last Update Posted : September 27, 2019